Global High-Priority Regulatory Events — February 04, 2026

05-02-2026

Peloton Interactive, Inc. filed an 8-K on February 5, 2026, reporting results of operations and financial condition under Item 2.02, an officer change or election/appointment under Item 5.02, Regulation FD disclosure under Item 7.01, and financial statements/exhibits under Item 9.01. Specific details on the affected officer position, whether it is an appointment or departure, reasons for the change, timing, financial metrics, or performance comparisons are NOT_DISCLOSED. No quantitative data, named executives, or scheduled events are provided in the filing summary.

05-02-2026

05-02-2026

05-02-2026

05-02-2026

05-02-2026

05-02-2026

05-02-2026

05-02-2026

05-02-2026

05-02-2026

05-02-2026

Brand Engagement Network Inc. filed an 8-K on 2026-02-05 disclosing under Item 1.02 the termination of a material definitive agreement. Item 9.01 reports financial statements and exhibits. No details on the agreement parties, value, financial impact, or strategic context were provided.

05-02-2026

SPACSphere Acquisition Corp. filed an 8-K on 2026-02-05 disclosing Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 5.03 covers amendments to articles of incorporation or bylaws or change in fiscal year, while Item 9.01 includes financial statements and exhibits. No quantitative metrics, deal terms, personnel names, amendment details, or merger/acquisition specifics were explicitly stated.

05-02-2026

Planet Labs PBC filed a Form 8-K on February 5, 2026, disclosing events under Item 3.02 (Unregistered Sales of Equity Securities), Item 3.03 (Material Modifications to Rights of Security Holders), and Item 8.01 (Other Events). This is a multi-item filing with no specific transaction values, share counts, financial metrics, or period-over-period comparisons provided. Critical details such as dollar amounts, impacts, or strategic context are NOT_DISCLOSED.

05-02-2026

UPEXI, INC. filed an 8-K on 2026-02-05 disclosing the termination of a material definitive agreement under Item 1.02. The filing also reports financial statements and exhibits under Item 9.01. No details on the agreement, transaction value, financial impact, or other metrics were provided.

05-02-2026

Fly-E Group, Inc. filed an 8-K on 2026-02-05 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on key positions affected, individuals involved, reasons for change, or timing are provided. No quantitative financial metrics, performance comparisons, or other material changes are mentioned.

05-02-2026

Trailblazer Merger Corp I filed an 8-K on 2026-02-05 under Item 8.01 Other Events related to a merger/acquisition event. No quantitative metrics, deal structure details, financial terms, parties involved, strategic rationale, or timelines were explicitly stated in the filing summary. Sector is not specified, and all key transaction information remains NOT_DISCLOSED.

05-02-2026

05-02-2026

Broadwind, Inc. filed a Form 8-K on 2026-02-05 reporting multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 2.02 (Results of Operations and Financial Condition), 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory disclosure with no specific transaction details, dollar values, financial metrics, positive or negative changes, or period-over-period comparisons provided in the available information. Critical quantitative and qualitative details are NOT_DISCLOSED, limiting assessment of impacts.

05-02-2026

urban-gro, Inc. filed a Form 8-K on 2026-02-05 disclosing under Item 3.03 material modifications to rights of security holders, Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the modifications, amendments, or disclosures provided in the available information. No quantitative metrics, financial impacts, or directional performance indicators are mentioned.

05-02-2026

05-02-2026

P10, Inc. filed a Form 8-K on 2026-02-05 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on transaction terms, values, parties, or financial impacts disclosed. No quantitative metrics, period-over-period comparisons, or scheduled events are mentioned.

05-02-2026

Sotera Health Co filed a Form 8-K on 2026-02-05 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individual names, appointment or resignation status, reasons for change, or any quantitative data are disclosed. Sector information is NOT_DISCLOSED.

05-02-2026

Jerash Holdings (US), Inc. filed a Form 8-K on February 5, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement, events, or exhibits provided in the available information. No quantitative metrics, positive or negative changes, or period-over-period comparisons are mentioned.

05-02-2026

Imunon, Inc. filed an 8-K on 2026-02-05 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01. No specific details on affected positions, individuals involved, appointment/resignation status, reasons, timing, or any quantitative data are disclosed. Sector is not specified.

05-02-2026

STAAR Surgical Co filed an 8-K on 2026-02-05 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific names, positions affected, reasons for the change, timing details, or quantitative data such as compensation amounts are provided in the filing summary. No positive or negative metrics are mentioned.

05-02-2026

CORPAY, INC. filed an 8-K on 2026-02-05 announcing the completion of an acquisition or disposition of assets under Item 2.01. The filing includes financial statements and exhibits under Item 9.01. No specific details on deal structure, parties, valuation, or financial impact are disclosed.

05-02-2026

Central Bancompany, Inc. filed an 8-K on 2026-02-05 disclosing officer changes or appointments under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on affected positions, names, reasons for changes, timing, or any quantitative financial metrics are disclosed. This is an informational filing with no period-over-period comparisons or directional performance indicators provided.

05-02-2026

Sonim Technologies Inc filed an 8-K on 2026-02-05 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). Specific details including key position affected, appointment or resignation status, reasons for change, timing, or any compensatory terms are NOT_DISCLOSED. No quantitative metrics, financial data, or performance comparisons are provided in the filing summary.

05-02-2026

Profusa, Inc. filed an 8-K on 2026-02-05 reporting under Item 3.03 material modifications to rights of security holders, Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, Item 8.01 other events, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the nature of modifications, amendments, events, or exhibits provided. No quantitative data, financial impacts, or directional biases are disclosed.

05-02-2026

ETHZilla Corp filed an 8-K on 2026-02-05 disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), indicating a merger/acquisition event has closed. The filing also addresses departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements (Item 5.02), along with Regulation FD disclosure (Item 7.01) and financial statements/exhibits (Item 9.01). No specific transaction details, financial metrics, parties involved, or performance impacts—positive or negative—are disclosed.

05-02-2026

05-02-2026

LB Pharmaceuticals Inc filed a Form 8-K on February 5, 2026, disclosing multiple items including entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements and exhibits (Item 9.01). No quantitative financial details, transaction sizes, or performance metrics were provided in the filing summary. This multi-item filing signals potentially significant strategic developments but lacks specifics on impacts.

05-02-2026

MKS INC filed a Form 8-K on February 05, 2026, disclosing entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, accompanied by Regulation FD disclosure under Item 7.01 and financial statements/exhibits under Item 9.01. No specific details on the nature of the agreement, transaction size, financial terms, or impacts are provided in the filing summary. This is a multi-item filing with no quantified positive or negative metrics disclosed.

05-02-2026

Amphenol Corp /DE/ filed an 8-K on 2026-02-05 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the affected officer, position, appointment or resignation, reasons, or timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other numerical data are mentioned.

05-02-2026

3M CO filed an 8-K on February 05, 2026 (AccNo: 0000066740-26-000037) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individuals involved, reasons for the change, or any financial metrics are disclosed. No positive or negative implications can be assessed due to lack of details.

05-02-2026

Post Holdings, Inc. filed an 8-K on February 5, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure in Item 7.01 and Financial Statements and Exhibits in Item 9.01. No specific details on the affected position, individual involved, reason for change, or timing are disclosed. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

05-02-2026

STRATUS PROPERTIES INC filed an 8-K on 2026-02-05 disclosing entry into a material definitive agreement under Item 1.01 and completion of an acquisition or disposition of assets under Item 2.01. Item 8.01 covers other events, and Item 9.01 includes financial statements and exhibits. No specific transaction details, parties, valuations, or financial metrics are disclosed.

05-02-2026

05-02-2026

VSE Corp filed a Form 8-K on 2026-02-05 disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 provides for financial statements and exhibits. No specific details on the agreement terms, transaction value, financial impacts, or other metrics are disclosed.

05-02-2026

Warner Music Group Corp. filed an 8-K on February 5, 2026 (AccNo: 0001193125-26-038593), reporting solely under Item 1.01 for entry into a Material Definitive Agreement. No details on the nature of the agreement, transaction value, parties involved, financial impacts, or strategic implications are disclosed. This represents a mandatory disclosure of a material event without accompanying quantitative metrics or comparisons.

05-02-2026

Strata Critical Medical, Inc. filed an 8-K on February 5, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction terms, financial impacts, or quantitative metrics are disclosed in the provided filing summary. This is a multi-item filing with no mentioned positive or negative performance metrics.

• ·Filing Accession Number: 0001104659-26-010689
• ·Filing size: 1 MB
• ·Sector: NOT_DISCLOSED

05-02-2026

Agape ATP Corp filed a Form 8-K on 2026-02-05 under Item 3.01 announcing a notice of delisting or failure to satisfy a continued listing rule or standard, with additional Regulation FD disclosure under Item 7.01 and financial statements/exhibits under Item 9.01. This multi-item filing signals a material compliance failure leading to delisting from the US market. No financial metrics, transaction values, dollar impacts, or other quantitative details are disclosed.

05-02-2026

EQV Ventures Acquisition Corp. filed an 8-K on 2026-02-05 under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) announcing a merger/acquisition event. No specific details on deal structure, parties involved, valuation, financial terms, strategic rationale, or quantitative metrics are disclosed. All key transaction and financial data remain NOT_DISCLOSED.

05-02-2026

AMN Healthcare Services Inc. filed an 8-K on February 5, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individuals involved, nature of the change (appointment or resignation), reasons, or timing are disclosed. No quantitative financial metrics, performance comparisons, or other material impacts are mentioned.

05-02-2026

FOCUS UNIVERSAL INC. filed a Form 8-K on 2026-02-05 under Item 3.03 disclosing material modifications to rights of security holders, Item 5.03 disclosing amendments to articles of incorporation or bylaws or change in fiscal year, and Item 9.01 for financial statements and exhibits. No specific details, quantitative metrics, positive or negative impacts, or financial implications are disclosed in the provided filing summary. This is a multi-item mandatory filing with no extracted numbers or period-over-period comparisons.

• ·Accession Number: 0001683168-26-000776
• ·Sector: NOT_DISCLOSED

05-02-2026

Franklin Resources Inc filed an 8-K on 2026-02-05 disclosing an officer change or director election under Item 5.02, including compensatory arrangements of certain officers, and submission of matters to a vote of security holders under Item 5.07. No specific details on the key position affected, names, reasons for change, vote outcomes, or any quantitative data such as share counts or percentages are disclosed. This appears to be routine governance disclosure with no further context provided.

05-02-2026

Virginia National Bankshares Corp filed an 8-K on 2026-02-05 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references financial statements and exhibits. No specific details on the officer, position, reason for change, or any quantitative metrics are disclosed.

05-02-2026

Target Corp filed an 8-K on February 5, 2026 (AccNo: 0000027419-26-000004), disclosing information under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or timing are provided in the available information. No quantitative metrics, financial impacts, or performance comparisons are mentioned.

05-02-2026

LanzaTech Global, Inc. filed an 8-K on 2026-02-05 disclosing officer changes under Item 5.02, which covers departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for changes, or any quantitative terms are disclosed.

05-02-2026

Iron Horse Acquisition II Corp. filed an 8-K on 2026-02-05 under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits), announcing a merger/acquisition event. No specific deal terms, parties, financial metrics, or quantitative data are disclosed in the provided filing summary. The attachment size is 264 KB, suggesting exhibits such as press releases or agreements may be included, but details are NOT_DISCLOSED.

• ·AccNo: 0001213900-26-012738
• ·Filing size: 264 KB
• ·Sector: NOT_DISCLOSED

05-02-2026

WM Technology, Inc. filed a Form 8-K on February 5, 2026 (AccNo: 0001779474-26-000005), reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing from the US market. No financial metrics, transaction values, or additional details such as reasons for delisting, impacts, or scheduled events are disclosed. This event represents a material negative development with no offsetting positive information provided.

• ·Filing date: 2026-02-05
• ·Accession Number: 0001779474-26-000005
• ·File size: 189 KB
• ·Event Type: Delisting

05-02-2026

Athena Technology Acquisition Corp. II filed an 8-K on 2026-02-05 disclosing a merger/acquisition event under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on deal structure, parties involved, valuation, financial terms, or metrics are disclosed in the provided filing information. This announcement provides informational context but lacks quantitative data for impact assessment.

05-02-2026

SunPower Inc. filed an 8-K on 2026-02-05 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates financial statements and exhibits were included. Specific details on the officer(s) involved, position, appointment/resignation status, reasons, timing, or impacts are NOT_DISCLOSED.

05-02-2026

IR-Med, Inc. filed a Form 8-K on February 5, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 3.02 unregistered sales of equity securities, and under Item 5.02 departures of directors or certain officers, elections or appointments of directors or officers, and compensatory arrangements of certain officers. Item 9.01 discloses financial statements and exhibits. No specific transaction values, share counts, financial metrics, or period-over-period comparisons are mentioned.

05-02-2026

Newton Golf Company, Inc. filed an 8-K on February 5, 2026 (AccNo: 0001493152-26-005257) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on key positions affected, individuals involved, reasons for change, timing, or any quantitative data are explicitly stated. Sector is not specified.

05-02-2026

NOVAGOLD RESOURCES INC filed a Form 8-K on February 05, 2026, reporting entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, and Regulation FD disclosure under Item 7.01, with exhibits under Item 9.01. This is a multi-item filing with no specific transaction values, share counts, financial impacts, or quantitative metrics disclosed. The disclosures appear informational without detailed positive or negative performance indicators.

05-02-2026

KALA BIO, Inc. filed an 8-K on February 5, 2026, disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names of individuals, positions affected, reasons for changes, timing, or any financial metrics are provided in the available information. No positive or negative metrics are mentioned, resulting in a neutral informational filing.

05-02-2026

Smith Micro Software, Inc. filed a Form 8-K on 2026-02-05 reporting under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and under Item 3.02 unregistered sales of equity securities, with exhibits under Item 9.01. This is a multi-item mandatory disclosure, but specific details including transaction values, share counts, agreement terms, or financial impacts are NOT_DISCLOSED. No positive or negative metrics, period-over-period changes, or guidance revisions are mentioned.

05-02-2026

Beam Therapeutics Inc. filed an 8-K on 2026-02-05 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, timing, or impacts are provided in the filing summary. No quantitative data, financial metrics, or other changes mentioned.

05-02-2026

Mastercard Inc filed an 8-K on February 5, 2026 (AccNo: 0001141391-26-000006), under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, positions, reasons for change, timing, or any quantitative information are explicitly stated. No positive or negative metrics are provided, resulting in purely informational disclosure.

05-02-2026

Doximity, Inc. filed an 8-K on February 5, 2026, disclosing results of operations and financial condition under Item 2.02 and an officer change involving departure, election, appointment, or compensatory arrangements under Item 5.02. Financial statements and exhibits are referenced under Item 9.01. Specific details including names, positions, reasons for change, financial metrics, or performance comparisons are NOT_DISCLOSED.

05-02-2026

Lulu's Fashion Lounge Holdings, Inc. filed an 8-K on 2026-02-05 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure in Item 7.01 and Financial Statements and Exhibits in Item 9.01. Specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, or any named individuals are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or governance impacts are mentioned.

05-02-2026

MONOLITHIC POWER SYSTEMS INC filed an 8-K on 2026-02-05 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). Specific details on the leadership change, including key position affected, appointment or resignation status, reasons, timing, financial metrics, or performance comparisons, are NOT_DISCLOSED.

05-02-2026

Oracle Corp filed an 8-K on February 5, 2026, disclosing under Item 1.01 entry into a material definitive agreement, Item 3.03 material modifications to rights of security holders, Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, and Item 9.01 financial statements and exhibits. No specific details on the agreement, modifications, amendments, transaction values, financial impacts, or quantitative metrics are disclosed. This is a multi-item mandatory filing with no period-over-period comparisons or named entities provided.

05-02-2026

Artelo Biosciences, Inc. filed an 8-K on 2026-02-05 reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 3.02 (Unregistered Sales of Equity Securities), with exhibits under Item 9.01. No specific details on the agreement, transaction value, share counts, or financial impacts are disclosed. This is a multi-item mandatory filing with no period-over-period metrics or guidance provided.

05-02-2026

Newbridge Acquisition Ltd filed an 8-K on 2026-02-05 under AccNo: 0001213900-26-012753, disclosing other events under Item 8.01 and financial statements/exhibits under Item 9.01 in connection with a merger/acquisition event. No specific transaction details, financial metrics, parties involved, or quantitative data are disclosed in the filing summary provided. Sector is not specified.

• ·Filing size: 382 KB
• ·Accession Number: 0001213900-26-012753

05-02-2026

QuidelOrtho Corp filed an 8-K on February 5, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Specific details including the key position affected, individuals involved, appointment or resignation status, reasons for the change, and any timing are NOT_DISCLOSED. No quantitative data, financial metrics, or further governance implications are provided in the filing summary.

05-02-2026

Dave Inc. (DE) filed an 8-K on 2026-02-05 announcing the completion of an acquisition or disposition of assets under Item 2.01. Financial statements and exhibits are included under Item 9.01. No details on transaction parties, structure, value, or strategic rationale are disclosed.

05-02-2026

Arhaus, Inc. filed an 8-K on 2026-02-05 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on the affected officer, position, appointment or resignation status, reasons, or timing are disclosed.

05-02-2026

McGrath RentCorp filed an 8-K on 2026-02-05 disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 5.03 covers amendments to articles of incorporation or bylaws, or change in fiscal year. Item 9.01 references financial statements and exhibits; no specific details, names, reasons, or quantitative impacts are disclosed.

• ·AccNo: 0001193125-26-039337
• ·Filing Size: 473 KB

05-02-2026

Power Integrations Inc filed a Form 8-K on 2026-02-05 reporting entry into a material definitive agreement (Item 1.01), results of operations and financial condition (Item 2.02), costs associated with exit or disposal activities (Item 2.05 indicating potential negative restructuring expenses), and other events (Item 8.01), with financial statements and exhibits (Item 9.01). This multi-item filing signals significant developments but lacks specific details on transaction size, financial metrics, or impacts. No quantitative data such as dollar values, percentages, or period-over-period comparisons is disclosed.

05-02-2026

Lexeo Therapeutics, Inc. filed an 8-K on 2026-02-05 under Item 5.02 disclosing departure of directors or certain officers; election of directors; appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any quantitative data are disclosed in the provided filing information. Sector is not specified.

05-02-2026

Simon Property Group Inc. filed an 8-K on February 5, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on individuals, positions, reasons, timing, or impacts are disclosed.

05-02-2026

LEE Enterprises, Inc. filed a multi-item Form 8-K on February 5, 2026, reporting events under Items 1.01 (Entry into Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 3.03 (Material Modifications to Rights of Security Holders), 5.01 (Changes in Control), 5.02 (Changes in Directors/Officers), 5.03 (Amendments to Articles/Bylaws), 5.07 (Submission of Matters to Shareholder Vote), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific transaction details, financial metrics, dollar values, share counts, or quantitative impacts are disclosed in the provided filing summary. This appears to signal a significant corporate restructuring or transaction involving control changes and governance updates.

05-02-2026

Sunshine Biopharma Inc. filed an 8-K on 2026-02-05 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative data such as compensation amounts are disclosed in the provided information. Sector is not specified.

• ·AccNo: 0001683168-26-000789
• ·File Size: 232 KB
• ·Event Date: 2026-02-05

05-02-2026

Verizon Communications Inc filed an 8-K on 2026-02-05 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for the change, or any quantitative metrics such as compensation amounts are provided. No positive or negative performance metrics mentioned.

• ·AccNo: 0001193125-26-039415
• ·File Size: 425 KB
• ·Sector: NOT_DISCLOSED

05-02-2026

GREENLIGHT CAPITAL RE, LTD. filed an 8-K on 2026-02-05 (AccNo: 0001385613-26-000003, Size: 141 KB) under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on key positions affected, whether appointment or resignation, reasons for the change, timing, internal/external status, or board impacts are disclosed. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

• ·Event date: February 05, 2026
• ·Source: us_sec

05-02-2026

TEN Holdings, Inc. filed an 8-K on 2026-02-05 disclosing officer changes under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside other events in Item 8.01 and exhibits in Item 9.01. No specific details on the affected position (e.g., CEO, CFO), appointment/resignation status, reasons, or timing are disclosed. No quantitative metrics, financial impacts, or performance comparisons are mentioned.

05-02-2026

First Citizens Bancshares Inc./DE/ filed a Form 8-K on February 5, 2026, reporting under Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the nature of the modifications, amendments, events, or exhibits provided. No quantitative financial metrics, positive or negative changes, or scheduled events are disclosed.

05-02-2026

MITEK SYSTEMS INC filed a multi-item Form 8-K on February 05, 2026, reporting the termination of a material definitive agreement under Item 1.02, results of operations and financial condition under Item 2.02, departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements under Item 5.02, Regulation FD disclosure under Item 7.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific financial metrics, transaction values, dollar amounts, percentages, or period-over-period comparisons were disclosed. The combination of agreement termination and officer changes suggests potential disruptions, while financial results details remain undisclosed.

05-02-2026

BNB PLUS CORP. filed an 8-K on 2026-02-05 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the affected officer, position, appointment/resignation status, reasons, or timing are NOT_DISCLOSED.

05-02-2026

Granite Ridge Resources, Inc. filed an 8-K on 2026-02-05 disclosing an officer or director change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on affected positions, individuals, reasons, timing, or impacts are disclosed.

05-02-2026

BOSTON SCIENTIFIC CORP filed an 8-K on 2026-02-05 under Item 5.02 disclosing departure of directors or certain officers; election of directors; appointment of certain officers; or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any financial metrics are disclosed. This represents a standard governance event with no quantified positive or negative impacts provided.

05-02-2026

Fidelity Ethereum Fund filed an 8-K on February 05, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, timing, or impacts are disclosed. This is a standard governance disclosure with no quantitative metrics or further context provided.

05-02-2026

Toll Brothers, Inc. filed a Form 8-K on 2026-02-05 under Item 1.01 disclosing entry into a material definitive agreement and Item 9.01 for financial statements and exhibits. This is a multi-item mandatory filing with no specific details on the agreement provided. No financial metrics, transaction values, or impacts are disclosed.

05-02-2026

ABM Industries Inc. filed a Form 8-K on February 5, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No quantitative details such as transaction value, terms, financial impacts, or period-over-period comparisons are provided in the filing summary.

05-02-2026

Fidelity Wise Origin Bitcoin Fund filed a Form 8-K on February 5, 2026, disclosing entry into a material definitive agreement under Item 1.01 and departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements under Item 5.02, accompanied by financial statements and exhibits under Item 9.01. No specific details on the agreement, personnel changes, financial impacts, or quantitative metrics are provided in the available information. This multi-item filing appears informational without disclosed positive or negative performance metrics.

05-02-2026

Fidelity Solana Fund filed an 8-K on February 5, 2026 (AccNo: 0001193125-26-039510), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, timing, or any quantitative impacts are disclosed. Sector is not specified.

05-02-2026

MasterCraft Boat Holdings, Inc. filed a Form 8-K on February 5, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 includes financial statements and exhibits. No specific transaction values, financial metrics, personnel names, or other quantitative details are disclosed.

05-02-2026

Vivakor, Inc. filed a Form 8-K on 2026-02-05 disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 references financial statements and exhibits. No specific details on the agreement, transaction value, financial impacts, or performance metrics are disclosed.

05-02-2026

PAID INC filed an 8-K on 2026-02-05 reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, financial impacts, or other metrics are disclosed. This is a multi-item filing focused on a material event with attached exhibits.

05-02-2026

Limoneira CO filed an 8-K on 2026-02-05 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons, or financial impacts are disclosed.

05-02-2026

EGH Acquisition Corp. filed an 8-K on 2026-02-05 (AccNo: 0001104659-26-010934) disclosing information under Item 7.01 Regulation FD Disclosure and providing Financial Statements and Exhibits under Item 9.01. The filing relates to a Merger/Acquisition event but contains no explicit details on structure, parties, valuation, or financial terms. No quantitative metrics, comparisons, or scheduled events are mentioned.

05-02-2026

Fluent, Inc. filed an 8-K on February 5, 2026 (AccNo: 0001437749-26-003216), reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No transaction details, financial metrics, dollar values, or impacts are specified.

• ·Filing size: 448 KB
• ·Source: us_sec

05-02-2026

Cathay General Bancorp filed an 8-K on February 5, 2026 (AccNo: 0001437749-26-003217, Size: 161 KB), disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions (e.g., CEO, CFO), individuals involved, reasons for change, internal/external status, timing, or any quantitative data such as compensation are explicitly stated. This is an informational governance filing with no disclosed positive or negative metrics.

05-02-2026

United Acquisition Corp. I filed an 8-K on 2026-02-05 under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits), in connection with a merger/acquisition event. No specific details on deal structure, parties involved, financial terms, valuations, synergies, or impacts are disclosed in the filing summary provided. No quantitative metrics, comparisons, or scheduled events are mentioned.

05-02-2026

Marine Products Corp filed an 8-K on 2026-02-05 disclosing entry into a material definitive agreement under Item 1.01. Item 9.01 includes financial statements and exhibits. No specific details, dollar values, financial impacts, or other metrics are disclosed.

05-02-2026

Eightco Holdings Inc. filed a Form 8-K on 2026-02-05 reporting Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no quantitative financial metrics, transaction values, or specific details on the modifications or amendments disclosed. No positive or negative performance metrics provided.

05-02-2026

Nano Nuclear Energy Inc. filed an 8-K on 2026-02-05 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also references Item 9.01 for Financial Statements and Exhibits. No specific details on the affected officer, position, reason for change, timing, or compensatory terms are disclosed.

05-02-2026

MGX Resources Limited (ASX: MGX) announced the completion of its acquisition of CTPJV on February 05, 2026. No details on deal structure, financial terms, strategic rationale, offer premiums, conditions, or regulatory approvals are disclosed. This completion eliminates deal execution risk, though merits and impacts cannot be assessed without further information.

05-02-2026

NeoVolta Inc. filed an 8-K on February 5, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing were disclosed. No quantitative financial metrics, performance comparisons, or other material data were provided.

05-02-2026

Consumer Portfolio Services, Inc. filed an 8-K on February 5, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). No specific details on positions affected, individuals involved, reasons for the change, or any financial metrics are disclosed. No positive or negative metrics are mentioned.

05-02-2026

Colombier Acquisition Corp. III filed an 8-K on 2026-02-05 disclosing entry into a material definitive agreement under Item 1.01, likely related to a merger or acquisition event. The filing also includes unregistered sales of equity securities (Item 3.02), departures/elections of directors/officers and compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws (Item 5.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific transaction details, financial metrics, parties involved, or performance indicators are disclosed.

05-02-2026

DSS, Inc. filed an 8-K on February 5, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details on the agreement, events, transaction value, financial metrics, or performance comparisons (positive, negative, or flat) are disclosed in the provided filing information.

05-02-2026

Hilltop Holdings Inc. filed an 8-K on 2026-02-05 disclosing officer or director changes under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on the key position affected, individuals involved, reasons for the change, timing, or any quantitative data such as compensation amounts are disclosed. This appears to be a routine governance disclosure with no mentioned financial metrics or performance impacts.

05-02-2026

Forum Energy Technologies, Inc. filed an 8-K on February 5, 2026, disclosing entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or an obligation under an off-balance sheet arrangement under Item 2.03. Item 9.01 includes financial statements and exhibits. No transaction details, financial metrics, dollar values, or impacts are disclosed in the provided filing summary.

05-02-2026

AIRWA INC. filed an 8-K on 2026-02-05 disclosing entry into a material definitive agreement under Item 1.01 and completion of an acquisition or disposition of assets under Item 2.01. Item 9.01 includes financial statements and exhibits. No specific deal terms, parties, valuations, synergies, or performance metrics are disclosed.

05-02-2026

Blink Charging Co. filed an 8-K on 2026-02-05 disclosing officer or director changes under Item 5.02, including departures, elections, appointments, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals, reasons, or quantitative impacts are disclosed.

05-02-2026

CaliberCos Inc. filed an 8-K on 2026-02-05 disclosing Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 5.07 (Submission of Matters to a Vote of Security Holders), and Item 9.01 (Financial Statements and Exhibits). Specific details on affected positions, reasons for changes, vote outcomes, amendment descriptions, or any quantitative metrics are NOT_DISCLOSED. No positive or negative performance metrics are mentioned.

05-02-2026

Faraday Future Intelligent Electric Inc. filed a Form 8-K on February 5, 2026, reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with financial statements and exhibits attached under Item 9.01. This is a multi-item mandatory disclosure with no specific details on the agreement terms, transaction size, or financial impacts provided. No positive or negative metrics, changes, or comparisons are disclosed.

05-02-2026

Kodiak Gas Services, Inc. filed a Form 8-K on February 05, 2026, disclosing entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, and Regulation FD disclosure under Item 7.01, with exhibits under Item 9.01. No specific details on the agreement, transaction size, financial impacts, or equity sales volumes are provided in the filing summary. This multi-item filing appears informational without quantified positive or negative metrics.

05-02-2026

Fluor Corp filed a Form 8-K on 2026-02-05 under Item 5.02 disclosing a change involving the departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, titles, reasons for the change, timing, or financial terms are provided in the available information. This appears to be a standard governance disclosure with no quantitative metrics or performance impacts mentioned.

05-02-2026

Kaival Brands Innovations Group, Inc. filed an 8-K on 2026-02-05 under Item 5.02 disclosing departure of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements of certain officers. The filing also covers Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, and Item 9.01 financial statements and exhibits. No specific details on affected positions, individuals, reasons for changes, quantitative data, or scheduled events are disclosed.

05-02-2026

Stoneridge Inc filed an 8-K on February 5, 2026, disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on individuals, reasons, timing, or impacts are disclosed.

05-02-2026

K2 Capital Acquisition Corp filed an 8-K on 2026-02-05 disclosing an other event under Item 8.01 and financial statements and exhibits under Item 9.01, labeled as related to a Merger/Acquisition event. No specific details on deal structure, parties, valuation, financial metrics, or impacts are explicitly stated. Sector is not specified.

05-02-2026

Wellgistics Health, Inc. filed an 8-K on February 5, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals, reasons for changes, or quantitative impacts are disclosed.

05-02-2026

Charlton Aria Acquisition Corp filed an 8-K on 2026-02-05 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific names, dates, financial terms, transaction details, or quantitative metrics are mentioned. This filing pertains to personnel changes rather than a merger or acquisition.

05-02-2026

NKGen Biotech, Inc. filed an 8-K on 2026-02-05 disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, financial impacts, or other quantitative metrics are disclosed.

05-02-2026

Dune Acquisition Corp II filed an 8-K on February 05, 2026, disclosing entry into a material definitive agreement under Item 1.01, changes in control of the registrant under Item 5.01, departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements under Item 5.02, along with financial statements and exhibits under Item 9.01. No quantitative financial metrics, deal terms, or performance comparisons were disclosed in the filing summary. The filing signals a significant corporate transaction but lacks details on outcomes or impacts.

05-02-2026

AMERICAN REBEL HOLDINGS INC filed a Form 8-K on February 5, 2026, reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02. The filing also includes Regulation FD disclosure under Item 7.01 and financial statements and exhibits under Item 9.01. No quantitative details such as transaction values, share counts, financial impacts, or period-over-period comparisons were disclosed.